Explore the categories so you can find more about your search.

Categorie > Cholesterol

Spending On Cholesterol Reducing Statins More Than Doubles In Just Five Years, USA

Categorie : Cholesterol
Spending on statins, drugs used to reduce artery-clogging cholesterol, increased 156 percent between 2000 and 2005, according to the latest News and Numbers from the federal Agency for Healthcare Research and Quality. Statins can reduce a person's risk of heart attack or stroke by lowering "bad" ch ...

read more Spending on statins, drugs used to reduce artery-clogging cholesterol, increased 156 percent between 2000 and 2005, according to the latest News and Numbers from the federal Agency for Healthcare Research and Quality. Statins can reduce a person's risk of heart attack or stroke by lowering read more Tue Jul 2008 Tue Jul 2008

Pfizer And Ranbaxy Settle Lipitor Patent Litigation Worldwide

Categorie : Cholesterol
Pfizer Inc announced that it has entered into an agreement with generics manufacturer Ranbaxy Laboratories Ltd. of India and certain of its affiliates to settle substantially all their patent litigation worldwide involving Lipitor, the world's most-prescribed cholesterol-lowering medicine. Under the ...

read more Pfizer Inc announced that it has entered into an agreement with generics manufacturer Ranbaxy Laboratories Ltd. of India and certain of its affiliates to settle substantially all their patent litigation worldwide involving Lipitor, the world's most-prescribed cholesterol-lowering medicine. Under the read more Tue Jul 2008 Tue Jul 2008

Published Study Reveals Next Pharmaceuticals' Flavoxine? Reduces Multiple Heart Health Risk Factors Including High Cholesterol

Categorie : Cholesterol
Next Pharmaceuticals announced the results of their placebo-controlled, randomized, double-blind clinical trial, which revealed multiple heart health benefits of Flavoxine. The published study concluded that Flavoxine significantly reduced LDL-cholesterol and triglycerides, while it significantly de ...

read more Next Pharmaceuticals announced the results of their placebo-controlled, randomized, double-blind clinical trial, which revealed multiple heart health benefits of Flavoxine. The published study concluded that Flavoxine significantly reduced LDL-cholesterol and triglycerides, while it significantly de read more Tue Jul 2008 Tue Jul 2008

Fish Oil And Red Yeast Rice Studied For Lowering Blood Cholesterol

Categorie : Cholesterol
A great deal of scientific evidence shows that cholesterol-reducing medications known as statins can help prevent coronary artery disease. Although the safety of these medications has been well documented, as many as 40 percent of patients who receive a prescription for statins take the drug ...

read more A great deal of scientific evidence shows that cholesterol-reducing medications known as statins can help prevent coronary artery disease. Although the safety of these medications has been well documented, as many as 40 percent of patients who receive a prescription for statins take the drug read more Tue Jul 2008 Tue Jul 2008

New AAP Policy On Lipid Screening And Heart Health In Children

Categorie : Cholesterol
The American Academy of Pediatrics has issued new cholesterol screening and treatment recommendations for children. The policy statement, "Lipid Screening and Cardiovascular Health in Childhood," recommends cholesterol screening of children and adolescents with a family history of high cholesterol o ...

read more The American Academy of Pediatrics has issued new cholesterol screening and treatment recommendations for children. The policy statement, read more Tue Jul 2008 Tue Jul 2008

Tip Of The Week - 'Cholesterol'- Not All Bad

Categorie : Cholesterol
More and more people are aware of 'cholesterol' and how it increases the risk of heart disease. Some even know their cholesterol levels and may be controlling them through diet and lifestyle changes or with medication. Cholesterol is made in the liver and too much can cause arteries to fur up, but n ...

read more More and more people are aware of 'cholesterol' and how it increases the risk of heart disease. Some even know their cholesterol levels and may be controlling them through diet and lifestyle changes or with medication. Cholesterol is made in the liver and too much can cause arteries to fur up, but n read more Tue Jul 2008 Tue Jul 2008

New Research Shows That Artichoke Leaf Extract Lowers Cholesterol

Categorie : Cholesterol
Researchers at the University of Reading have found that an over-the-counter Artichoke Leaf Extract (ALE) from the globe artichoke plant can lower cholesterol in otherwise healthy individuals with moderately raised levels. Cardiovascular diseases are the chief causes of death in the UK, and are asso ...

read more Researchers at the University of Reading have found that an over-the-counter Artichoke Leaf Extract (ALE) from the globe artichoke plant can lower cholesterol in otherwise healthy individuals with moderately raised levels. Cardiovascular diseases are the chief causes of death in the UK, and are asso read more Tue Jul 2008 Tue Jul 2008

Prebiotic Potential Of Almonds

Categorie : Cholesterol
Almonds, as well as being high in vitamin E and other minerals, are also thought to have other health benefits, such as reducing cholesterol. Recently published work by the Institute of Food Research has identified potential prebiotic properties of almonds that could help improve our digestive healt ...

read more Almonds, as well as being high in vitamin E and other minerals, are also thought to have other health benefits, such as reducing cholesterol. Recently published work by the Institute of Food Research has identified potential prebiotic properties of almonds that could help improve our digestive healt read more Tue Jul 2008 Tue Jul 2008

TREDAPTIVETM (Nicotinic Acid /Laropiprant) Approved In The European Union: New Lipid-Modifying Therapy To Treat LDL-C, HDL-C And Triglycerides

Categorie : Cholesterol
Merck Sharp & Dohme (MSD) announced that TREDAPTIVE? (nicotinic acid/laropiprant, MSD) 1 g/20 mg modified-release tablets, a new lipid-modifying therapy for patients with dyslipidemia and primary hypercholesterolemia, has been approved for marketing in the European Union (EU), Iceland and Norway. ...

read more Merck Sharp & Dohme (MSD) announced that TREDAPTIVE? (nicotinic acid/laropiprant, MSD) 1 g/20 mg modified-release tablets, a new lipid-modifying therapy for patients with dyslipidemia and primary hypercholesterolemia, has been approved for marketing in the European Union (EU), Iceland and Norway. read more Tue Jul 2008 Tue Jul 2008

CocoaVia Dark Chocolate Bars Shown To Lower Cholesterol

Categorie : Cholesterol
The results of a University of Illinois study have demonstrated an effective way to lower cholesterol levels - by eating chocolate bars."Eating two CocoaVia dark chocolate bars a day not only lowered cholesterol, it had the unexpected effect of also lowering systolic blood pressure," said John Erdma ...

read more The results of a University of Illinois study have demonstrated an effective way to lower cholesterol levels - by eating chocolate bars. read more Thu Jun 2008 Thu Jun 2008

Lower Blood Pressure Linked To Statins

Categorie : Cholesterol
An article published in the Archives of Internal Medicinereports that statins - medications that are usually prescribed to lowerblood cholesterol levels - may also lower blood pressure. Beatrice A.Golomb, M.D., Ph.D., (University of California, San Diego, La Jolla)and colleagues noted a modest but s ...

read more An article published in the Archives of Internal Medicinereports that statins - medications that are usually prescribed to lowerblood cholesterol levels - may also lower blood pressure. Beatrice A.Golomb, M.D., Ph.D., (University of California, San Diego, La Jolla)and colleagues noted a modest but s read more Thu Jun 2008 Thu Jun 2008

Physicians And Patients Nationwide Discuss Controversial Results Of Recent Cholesterol Lowering Study

Categorie : Cholesterol
Sermo (http://www.sermo.com), the largest physician-only online community, today announced the results of a physician survey prompted by the swirl of media coverage following the release of ENHANCE trial data at the recent American College of Cardiology (ACC) conference. The focus of the study was o ...

read more Sermo (http://www.sermo.com), the largest physician-only online community, today announced the results of a physician survey prompted by the swirl of media coverage following the release of ENHANCE trial data at the recent American College of Cardiology (ACC) conference. The focus of the study was o read more Thu Jun 2008 Thu Jun 2008

Cholesterol, Blood Pressure Control May Reverse Atherosclerosis In Adults With Diabetes

Categorie : Cholesterol
Aggressively lowering cholesterol and blood pressure levels below current targets in adults with type 2 diabetes may help to prevent - and possibly reverse - hardening of the arteries, according to new research supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Instit ...

read more Aggressively lowering cholesterol and blood pressure levels below current targets in adults with type 2 diabetes may help to prevent - and possibly reverse - hardening of the arteries, according to new research supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Instit read more Thu Jun 2008 Thu Jun 2008

eFoodSafety Launches Cinnechol(TM), An All-Natural Alternative To Conventional Cholesterol Drugs

Categorie : Cholesterol
eFoodSafety.com (OTCBB: EFSF, http://www.efoodsafety.com), a researcher, developer, and marketer of whole food nutraceutical products, has launched an all-natural supplement, called Cinnechol? (http://www.cinnechol.com), that offers a complementary and/or alternative solution to traditional choleste ...

read more eFoodSafety.com (OTCBB: EFSF, http://www.efoodsafety.com), a researcher, developer, and marketer of whole food nutraceutical products, has launched an all-natural supplement, called Cinnechol? (http://www.cinnechol.com), that offers a complementary and/or alternative solution to traditional choleste read more Thu Jun 2008 Thu Jun 2008

Transporting Your Apolipoproteins Testing To The Next Level

Categorie : Cholesterol
Randox produces high quality apolipoprotein tests for the diagnosis, monitoring and research of cardiovascular disease and related conditions. Apolipoproteins are essential components of lipoproteins, for example HDL and LDL, responsible for transporting cholesterol and triglycerides around the bod ...

read more Randox produces high quality apolipoprotein tests for the diagnosis, monitoring and research of cardiovascular disease and related conditions. Apolipoproteins are essential components of lipoproteins, for example HDL and LDL, responsible for transporting cholesterol and triglycerides around the bod read more Thu Jun 2008 Thu Jun 2008

LifeCycle Pharma Announces Positive Data From LCP-AtorFen Phase II Clinical Program

Categorie : Cholesterol
LifeCycle Pharma A/S (OMX:LCP) announced positive results from the company's Phase II clinical program with LCP-AtorFen, a fixed-dose combination product of atorvastatin and fenofibrate for the treatment of mixed dyslipidemia. LCP-AtorFen is a convenient single tablet with a once-daily dosage profil ...

read more LifeCycle Pharma A/S (OMX:LCP) announced positive results from the company's Phase II clinical program with LCP-AtorFen, a fixed-dose combination product of atorvastatin and fenofibrate for the treatment of mixed dyslipidemia. LCP-AtorFen is a convenient single tablet with a once-daily dosage profil read more Thu Jun 2008 Thu Jun 2008

Sorting Of CEA Modulated By Cholesterol, Implications For Inflammatory Bowel Disease

Categorie : Cholesterol
In polarized Caco-2 cells, cholesterol was depleted by a combination of synthesis inhibition and plasma membrane extraction with complexing agents. This led to an increased sorting of CEA to the basolateral surface. Interestingly, polarity was not significantly affected by this approach. The associa ...

read more In polarized Caco-2 cells, cholesterol was depleted by a combination of synthesis inhibition and plasma membrane extraction with complexing agents. This led to an increased sorting of CEA to the basolateral surface. Interestingly, polarity was not significantly affected by this approach. The associa read more Thu Jun 2008 Thu Jun 2008

Effects Of Rimonabant On Cardiometabolic Risk Profile Include Loss Of Visceral Fat And Mobilization Of Liver Fat

Categorie : Cholesterol
At a late breaking presentation made on April 29th during the Annual meeting of the European Atherosclerosis Society held in Istanbul, the investigators of ADAGIO-LIPIDS presented the key findings of a one year trial aiming at further studying the effects of rimonabant on several features of ...

read more At a late breaking presentation made on April 29th during the Annual meeting of the European Atherosclerosis Society held in Istanbul, the investigators of ADAGIO-LIPIDS presented the key findings of a one year trial aiming at further studying the effects of rimonabant on several features of read more Thu Jun 2008 Thu Jun 2008

Merck Receives Not Approvable Letter From FDA For MK-0524A (ER Niacin/laropiprant)

Categorie : Cholesterol
Merck & Co., Inc. received a Not Approvable action letter from the U.S. Food and Drug Administration (FDA) for the Company's New Drug Application (NDA) for MK-0524A (ER niacin/laropiprant) for the treatment of primary hypercholesterolemia or mixed dyslipidemia. "We plan to meet with the FDA and to s ...

read more Merck & Co., Inc. received a Not Approvable action letter from the U.S. Food and Drug Administration (FDA) for the Company's New Drug Application (NDA) for MK-0524A (ER niacin/laropiprant) for the treatment of primary hypercholesterolemia or mixed dyslipidemia. read more Thu Jun 2008 Thu Jun 2008

Tredaptive Recommended For EU Approval For The Treatment Of Mixed Dyslipidaemia And Primary Hypercholesterolaemia

Categorie : Cholesterol
Merck Sharp & Dohme Limited (MSD) announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended marketing approval for 'Tredaptive'? (nicotinic acid/laropiprant, MSD) 1000 mg / 20 mg modified-release tablets for the treatment of mixed dyslipidaemia and primary hypercholest ...

read more Merck Sharp & Dohme Limited (MSD) announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended marketing approval for 'Tredaptive'? (nicotinic acid/laropiprant, MSD) 1000 mg / 20 mg modified-release tablets for the treatment of mixed dyslipidaemia and primary hypercholest read more Thu Jun 2008 Thu Jun 2008

1 | 2 | 3 | 4 next >>>



     


Custom Search